Cargando…

Nanomedicine for increasing the oral bioavailability of cancer treatments

ABSTRACT: Oral administration is an appealing route of delivering cancer treatments. However, the gastrointestinal tract is characterized by specific and efficient physical, chemical, and biological barriers that decrease the bioavailability of medications, including chemotherapeutics. In recent dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parodi, Alessandro, Buzaeva, Polina, Nigovora, Daria, Baldin, Alexey, Kostyushev, Dmitry, Chulanov, Vladimir, Savvateeva, Lyudmila V., Zamyatnin, Andrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557561/ https://www.ncbi.nlm.nih.gov/pubmed/34717658 http://dx.doi.org/10.1186/s12951-021-01100-2

Ejemplares similares

Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
por: Parodi, Alessandro, et al.
Publicado: (2022)

Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
por: Baldin, Alexey V., et al.
Publicado: (2020)

Structure determinants defining the specificity of papain-like cysteine proteases
por: Petushkova, Anastasiia I., et al.
Publicado: (2022)

Dead Cas Systems: Types, Principles, and Applications
por: Brezgin, Sergey, et al.
Publicado: (2019)

Overview of Celiac Disease in Russia: Regional Data and Estimated Prevalence
por: Savvateeva, Lyudmila V., et al.
Publicado: (2017)

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
por: Kolesova, Ekaterina P., et al.
Publicado: (2023)

Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure
por: Kostyusheva, Anastasiya, et al.
Publicado: (2018)

Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
por: Kostyusheva, Anastasiya, et al.
Publicado: (2021)

Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer
por: Batskikh, Sergey, et al.
Publicado: (2022)

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
por: Brezgin, Sergey, et al.
Publicado: (2023)

Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2020)

Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021)

Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2019)

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy
por: Rudzińska, Magdalena, et al.
Publicado: (2021)

Gene Editing by Extracellular Vesicles
por: Kostyushev, Dmitry, et al.
Publicado: (2020)

CRISPR-Cas systems for diagnosing infectious diseases
por: Kostyusheva, Anastasiya, et al.
Publicado: (2022)

Cellular Uptake and Transport Mechanism of 6-Mercaptopurine Nanomedicines for Enhanced Oral Bioavailability
por: Zou, Yaru, et al.
Publicado: (2023)

Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019)

CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions
por: Chulanov, Vladimir, et al.
Publicado: (2021)

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Rational Design of Recombinant Papain-Like Cysteine Protease: Optimal Domain Structure and Expression Conditions for Wheat-Derived Enzyme Triticain-α
por: Gorokhovets, Neonila V., et al.
Publicado: (2017)

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
por: Brezgin, Sergey, et al.
Publicado: (2021)

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

New Advances in the Understanding of Proteases as Diagnostic and Pharmaceutical Targets in Homeostatic and Pathologic Conditions
por: Zamyatnin, Andrey A., et al.
Publicado: (2022)

Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases
por: Brezgin, Sergey, et al.
Publicado: (2020)

Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia
por: Pimenov, Nikolay, et al.
Publicado: (2022)

ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage
por: Kostyusheva, Anastasiya, et al.
Publicado: (2019)

Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin
por: Umerska, Anita, et al.
Publicado: (2018)

Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro
por: Brezgin, Sergey, et al.
Publicado: (2019)

Cancer Vaccines: Antigen Selection Strategy
por: Zhao, Yue, et al.
Publicado: (2021)

Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment
por: Holmes, Eric H., et al.
Publicado: (2013)

Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles
por: Peñalva, Rebeca, et al.
Publicado: (2018)

Smart Nanotheranostics Responsive to Pathological Stimuli
por: Parodi, Alessandro, et al.
Publicado: (2020)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis
por: Bezerra-Souza, Adriana, et al.
Publicado: (2019)

The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability
por: Ma, Yiran, et al.
Publicado: (2012)

Albumin Nanovectors in Cancer Therapy and Imaging
por: Parodi, Alessandro, et al.
Publicado: (2019)

The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
por: Rudzińska, Magdalena, et al.
Publicado: (2019)

In Vitro and In Vivo Models for Evaluating the Oral Toxicity of Nanomedicines
por: Lama, Sudeep, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0dvdevucg7fpvl7u7u65oi1cv8